Publications     News     About    Contact

Solutions & Services

Therapeutic expertise

Why APICES

Facing Clinical Research Challenges? Here’s How to Succeed.
Biotechs rarely struggle with one issue at a time. This article breaks down the most common clinical research challenges, from resourcing and flexibility to regulatory complexity and quality, and explains how APICES supports teams to stay on track through every trial stage.

Biotechs operate under enormous pressure: they need to deliver solid scientific results, meet tight deadlines, manage limited resources, and navigate an increasingly demanding regulatory environment in our clinical research. With no room for error, success depends on finding the perfect balance between science, strategy, and execution. 

Partnering with a CRO with international experience and recognized excellence ensures these challenges are managed safely and efficiently, increasing the likelihood that your project progresses as planned and meets its objectives

Thanks to our extensive experience supporting Biotechs through every stage of their clinical trials, at APICES we know how to overcome challenges and achieve the results of each clinical research study

From the projects we have carried out with international Biotechs, we have learned to stay one step ahead of the challenges that concern Biotechs the most and to turn these challenges into opportunities

1- Limited resources vs. increasingly complex projects 

Our international experience allows us to optimize resources and planning, ensuring each phase is executed efficiently and that the trial’s milestones and objectives are met

We anticipate potential issues and adjust processes so the project progresses as planned, without compromising quality or scientific integrity. 

2- Real flexibility in a changing environment 

Every project has its own pace, and sometimes strategies need to be adjusted

We adapt our processes to provide agile, tailored solutions, supported by a Risk Management Plan that identifies and mitigates risks before they affect the trial, ensuring the study continues to meet its objectives even in the face of unexpected changes. 

3 – International regulatory complexity 

Legislative and regulatory requirements can pose a challenge for any clinical research project, especially when a trial spans multiple countries and sites

Having managed multicenter international trials, we have a deep understanding of local regulations, allowing us to prevent delays and regulatory obstacles, ensuring studies are conducted according to required standards and meet their endpoints. 

4 – Ensuring the highest quality in every process 

Ensuring quality in every process is key to producing results that accurately reflect the scientific objectives

At APICES, we place quality and scientific integrity at the heart of every decision, supported by Standard Operating Procedures (SOPsand validated systems, and recognized certifications (ISO 9001:2015; ISO 26000:2021; GRI; IQNET). This ensures trial results can be used with complete confidence. 

5 – Recognition and trust in the sector 

Our track record is backed by collaborations with Biotechs of various sizes and geographies, validating our operational excellence

This enables trials to not only comply with regulations and legislative requirements but also achieve their scientific and clinical objectives, providing a solid foundation of credibility with partners and regulators. 

We are proud to have received over 150 acknowledgments for our work, we remain committed to delivering excellence. 

6 – Experienced, aligned, and flexible team 

A large part of a trial’s success depends on the team managing it

We combine years of experience across therapeutic areas, deep regulatory and operational knowledge, and consolidated know-how paired with know-who in clinical sites and regulatory bodies. 

This combination allows us to anticipate risks, resolve issues, and ensure that milestones and endpoints are met at every stage. 

We act as a close, accessible, and reliable extension of your Biotech, and by taking care of comprehensive operational management, your team can focus on what truly matters: developing new therapies and advancing innovation. 

7 – Comprehensive support & stakeholder management 

Clinical development is complex and requires the coordination of multiple stakeholders. 

Close and effective management ensures the project progresses without setbacks. 

From initial planning to final steps, we provide a fully integrated service connecting all stakeholders, ensuring clear, accessible, and continuous communication, anticipating risks, and aligning expectations so that trial objectives are consistently achieved. 

8 – Maintaining focus on scientific innovation and patients 

At APICES, we take care of comprehensive operational management of the trial, freeing your team to focus on what truly matters: developing new therapies, advancing innovation, and achieving clinical objectives to improve patient quality of life and life expectancy. 

At APICES, we combine international experience, flexibility, and quality, working hand-in-hand with your team as a strategic partner that helps Biotechs achieve their clinical objectives. 

Are you planning your next clinical trial? 

Contact us and discover how we can help you overcome these challenges and achieve the best possible outcomes in your clinical research. 

Get the latest clinical insights delivered to your feed or inbox!

Interview with Oscar Salamanca, CEO of APICES

On integration, change leadership, and strengthening Apices as one unified organization  In a clinical research environment where sponsors value stability, predictability, and quality above all else, organizational change must be approached with care. As APICES...

APICES Acknowledged for its Role in GEOCP-SEOR Study 

APICES Acknowledged for its Role in GEOCP-SEOR Study 

Stage III NSCLC care sits at the intersection of multimodal treatment and real-world constraints. The GEOCP-SEOR population-based study describes how patients are managed across Spain, and APICES was acknowledged for supporting the publication through medical editorial assistance.